Beam Therapeutics: A 'Hold' Amid High Valuation And Uncertain Revenue Prospects
Bill Oxford Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology firm dedicated to developing precision genetic treatments. It uses base editing to correct single DNA letters, chemically changing one DNA base to another without the double-stranded …